Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A

Brain Research

Volumn 1177, Issue 1, 2007, Pages 9-18

  Onoprishvili, Irma ^a   Simon, Eric J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Filamin A; Melanoma cells; Morphine; Mu opioid receptor; Up regulation

Indexed keywords

ACTIN; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETONITAZENE; ETORPHINE; FILAMIN A; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LEVORPHANOL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PERTUSSIS TOXIN;

ARTICLE; BINDING SITE; CELL CLONE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DEFECT; RECEPTOR UPREGULATION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CONTRACTILE PROTEINS; DATA INTERPRETATION, STATISTICAL; DIPRENORPHINE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; MELANOMA; MICROFILAMENT PROTEINS; MORPHINE; NARCOTIC ANTAGONISTS; NARCOTICS; PERTUSSIS TOXIN; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; TUBULIN; UP-REGULATION;

EID: 35248823123     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.020     Document Type: Article

References (70)

1. Ancevska-Taneva N., Onoprishvili I., Andria M.L.., Hiller J.M., and Simon E.J. A member of the heat-shock protein 40 family, hlj 1, binds to the carboxyl tail of the human mu opioid receptor. Brain Res. 1081 (2006) 228-233
2. Awata H., Huang C., Handlogten M.E., and Miller R.T. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J. Biol. Chem. 276 (2001) 34871-34879
3. Baumhaker Y., Gafni M., Keren O., and Sarne Y. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 44 (1993) 461-467
4. Besse D., Lombard M.C., and Besson J.M. Time-related decreases in mu and delta opioid receptors in the superficial dorsal horn of the rat spinal cord following a large unilateral dorsal rhizotomy. Brain Res. 578 (1992) 115-121
5. Bhargava H.N., and Gulati A. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur. J. Pharmacol. 190 (1990) 305-311
6. Bot G., Blake A.D., Li S., and Reisine T. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells. Mol. Pharmacol. 52 (1997) 272-281
7. Brady L.S., Herkenham M., Long J.B., and Rothman R.B. Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 477 (1989) 382-386
8. Burd A.L., El-Kouhen R., Erickson L.J., Loh H.H., and Law P.-Y. Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the mu-opioid receptor. J. Biol. Chem. 273 (1998) 34488-34495
9. Capeyrou R., Riond J., Corbani M., Lepage J.F., Bertin B., and Emorine L.J. Agonist-induced signaling and trafficking of the μ-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain. FEBS Lett. 415 (1997) 200-205
10. Chaipatikul V., Erickson-Herbrandson L.J., Loh H.H., and Law P.Y. Rescuing the traffic-deficient mutants of rat mu-opioid receptors with hydrophobic ligands. Mol. Pharmacol. 64 (2003) 32-41
11. Chakrabarti S., Law P.Y., and Loh H.H. Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Brain Res. Mol. Brain Res. 30 (1995) 269-278
12. Chakrabarti S., Yang W., Law P.Y., and Loh H.H. The mu-opioid receptor downregulates differently from the delta-opioid receptor: requirement of a high-affinity receptor/G protein complex formation. Mol. Pharmacol. 52 (1997) 105-113
13. Chakrabarti S., Regec A., and Gintzler A.R. Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure. Brain Res. Mol. Brain Res. 135 (2005) 217-224
14. Chaturvedi K., Bandari P., Chinen N., and Howells R.D. Proteasome involvement in agonist-induced down-regulation of {micro} and delta opioid receptors. J. Biol. Chem. 276 (2001) 12345-12355
15. Cowen D.S., Molinoff P.B., and Manning D.R. 5-Hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells. Mol. Pharmacol. 52 (1997) 221-226
16. Cunningham C.C., Gorlin J.B., Kwiatkowski D.J., Hartwig J.H., Janmey P.A., Byers H.R., and Stossel T.P. Actin-binding protein requirement for cortical stability and efficient locomotion. Science 255 (1992) 325-327
17. Enz R. The actin-binding protein filamin-A interatcs with the metabotropic glutamate receptor type 7. FEBS Lett. 514 (2002) 184-188
18. Fabian G., Bozo B., Szikszay M., Horvath G., Coscia C.J., and Szucs M. Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain. J. Pharmacol. Exp. Ther. 302 (2002) 774-780
19. Fabian G., Tombor B., Nemeth I., Kicsi E.G., Szikszay M., Horvath G., and Szucs M. Upregulation of mu opioid receptors by voluntary morphine administration in drinking water. Acta Biol. Hung. 54 (2003) 157-166
20. Feng G.J., Kellett E., Scorer C.A., Wilde J., White J.H., and Milligan G. Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation. J. Biol. Chem. 278 (2003) 33400-33407
21. Ferguson S.S., and Caron M.G. G protein-coupled receptor adaptation mechanisms. Semin. Cell Dev. Biol. 9 (1998) 119-127
22. Filtz T.M., Guan W., Artymyshyn R.P., Facheco M., Ford C., and Molinoff P.B. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther. 271 (1994) 1574-1582
23. Finn A.K., and Whistler J.L. Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32 (2001) 829-839
24. Guang W., Wang H., Su T., Weinstein I.B., and Wang J.B. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol. Pharmacol. 66 (2004) 1285-1292
25. Hjalm G., macLeod R.J., Kifor O., Chattopadhyay N., and Brown E.M. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J. Biol. Chem. 276 (2001) 34880-34887
26. Holaday J.W., Hitzemann R.J., Curell J., Tortella F.C., and Belenky G.L. Repeated electroconvulsive shock or chronic morphine treatment increases the number of 3H-D-Ala2,d-Leu5-enkephalin binding sites in rat brain membranes. Life Sci. 31 (1982) 2359-2362
27. Horner K.A., and Zadina J.E. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res. 1028 (2004) 121-132
28. Kato S., Fukuda K., Morikawa H., Shoda T., Mima H., and Mori K. Adaptations to chronic agonist exposure of mu-opioid receptor-expressing Chinese hamster ovary cells. Eur. J. Pharmacol. 345 (1998) 221-228
29. Keith D.E., Anton B., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Monteillet-Agius G., Stewart P.L., Evans C.J., and von Zastrow M. Mu-opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 53 (1998) 377-384
30. Kim K.M., Gainetdinov R.R., Laporte S.A., Caron M.G., and Barak L.S. G protein coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. J. Biol. Chem. 280 (2005) 12774-12780
31. Koch T., Brandenburg L.O., Schulz S., Liang Y., Klein J., and Hollt V. ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis. J. Biol. Chem. 278 (2003) 9979-9985
32. Koch T., Widera A., Bartzsch K., Schulz S., Brandenburg L.O., Wundrack N., Beyer A., Grecksch G., and Hollt V. Receptor endocytosis counteracts the development of opioid tolerance. Mol. Pharmacol. 67 (2005) 280-287
33. Kurose H., Katada T., Amano T., and Ui M. Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma × glioma hybrid cells. J. Biol. Chem. 258 (1983) 4870-4875
34. Law P.Y., Wong Y.H., and Loh H.H. Mutational analysis of the structure and function of opioid receptors. Biopolymers 51 (1999) 440-455
35. Lefkowitz R.J. G protein-coupled receptors: III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273 (1998) 18677-18680
36. Lesscher H.M., Bailey A., Burbach J.P., Van Ree J.M., Kitchen I., and Gerrits M.A. Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice. Eur. J. Neurosci. 17 (2003) 1006-1012
37. Li M., Bermak J.C., Wang Z.W., and Zhou Q.Y. Modulation of dopamine D2 receptor signaling by actin-binding protein (ABP-280). Mol. Pharmacol. 57 (2000) 446-452
38. Lin R., Karpa K., Kabbani N., Goldman-Rakic P., and Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5258-5263
39. Meuser T., Giesecke T., Gabriel A., Horsch M., Sabatowski R., Hescheler J., Grond S., and Palmer P.P. Mu-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system. Anesth. Analg. 97 (2003) 1458-1463
40. Mitchell R., McCulloch D., Lutz E., Johnson M., MacKenzie C., Fennell M., Fink G., Zhou W., and Sealfon S.C. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392 (1998) 411-414
41. Narita M., Mizoguchi H., Nagase H., Suzuki T., and Tseng L.F. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment. Brain Res. 913 (2001) 170-173
42. Ng G.Y., Varghese G., Chung H.T., Trogadis J., Seeman P., O'Dowd B.F., and George S.R. Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology 138 (1997) 4199-4206
43. Onoprishvili I., Andria M., Vilim F., Hiller J., and Simon E. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. Mol. Brain Res. 73 (1999) 129-137
44. Onoprishvili I., Andria M.L., Kramer H.K., Ancevska-Taneva N., Hiller J.M., and Simon E.J. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking. Mol. Pharmacol. 64 (2003) 1092-1100
45. Pitcher J.A., Freedman N.J., and Lefkowitz R.J. G protein-coupled receptor kinases. Ann. Rev. Biochem. 67 (1998) 653-692
46. Polastron J., Meunier J.C., and Jauzac P. Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit. Eur. J. Pharmacol. 266 (1994) 139-146
47. Puttfarcken P.S., and Cox B.M. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci. 45 (1989) 1937-1942
48. Ray S.B., Gupta H., and Gupta Y.K. Up-regulation of m-opioid receptors in the spinal cord of morphine-tolerant rats. J. Biosci. 29 (2004) 51-56
49. Rothman R.B., Long J.B., Bykov V., Xu H., Jacobson A.E., Rice K.C., and Holaday J.W. Upregulation of the opioid receptor complex by the chronic administration of morphine: a biochemical marker related to the development of tolerance and dependence. Peptides 12 (1991) 151-160
50. Schmidt P., Schmolke C., Musshoff F., Menzen M., Prohaska C., and Madea B. Area-specific increased density of mu-opioid receptor immunoreactive neurons in the cerebral cortex of drug-related fatalities. Forensic Sci. Int. 133 (2003) 204-211
51. Seck T., Baron R., and Horne W.C. Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling. J. Biol. Chem. 278 (2003) 10408-10416
52. Stafford K., Gomes A.B., Shen J., and Yoburn B.C. mu-Opioid receptor downregulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 69 (2001) 233-237
53. Starr S., Kozell L.B., and Neve K.A. Drug-induced up-regulation of dopamine D2 receptors on cultured cells. J. Neurochem. 65 (1995) 569-577
54. Stossel T.P., Condeelis J., Cooley L., Hartwig J.H., Noegel A., Schleicher M., and Shapiro S.S. Filamins as integrators of cell mechanics and signalling. Nat. Rev., Mol. Cell Biol. 2 (2001) 138-145
55. Tempel A., Crain S.M., Peterson E.R., Simon E.J., and Zukin R.S. Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants. Brain Res. 390 (1986) 287-291
56. Trapaidze N., Keith D.E., Cvejic S., Evans C.J., and Devi L.A. Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271 (1996) 29279-29285
57. Tsao P., and von Zastrow M. Downregulation of G protein-coupled receptors. Curr. Opin. Neurobiol. 10 (2000) 365-369
58. Turchan J., Przewlocka B., Toth G., Lason W., Borsodi A., and Przewlocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 91 (1999) 971-977
59. Unterwald E.M., Rubenfeld J.M., Imai Y., Wang J.B., Uhl G.R., and Kreek M.J. Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Brain Res. Mol. Brain Res. 33 (1995) 351-355
60. Unterwald E.M., Anton B., Lam H., and Evans C.J. Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone. Neuroscience 85 (1998) 897-905
61. van der Flier A., and Sonnenberg A. Structural and functional aspects of filamins. Biochim. Biophys. Acta 1538 (2001) 99-117
62. Vigano D., Rubino T., Di Chiara G., Ascari I., Massi P., and Parolaro D. Mu opioid receptor signaling in morphine sensitization. Neuroscience 117 (2003) 921-929
63. Werling L.L., McMahon P.N., and Cox B.M. Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6393-6397
64. Yabaluri N., and Medzihradsky F. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol. Pharmacol. 52 (1997) 896-902
65. Yoburn B.C., Sierra V., and Lutfy K. Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur. J. Pharmacol. 170 (1989) 193-200
66. Zadina J.E., Chang S.L., Ge L.J., and Kastin A.J. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265 (1993) 254-262
67. Zadina J.E., Harrison L.M., Ge L.J., Kastin A.J., and Chang S.L. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 270 (1994) 1086-1096
68. Zhang L.J., Lachowicz J.E., and Sibley D.R. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol. Pharmacol. 45 (1994) 878-889
69. Zhang T., Xu Q., Chen F.R., Han Q.D., and Zhang Y.Y. Yeast two-hybrid screening for proteins that interact with alpha1-adrenergic receptors. Acta Pharm. Sin. 25 (2004) 1471-1478
70. Zukin R.S., and Tempel A. Neurochemical correlates of opiate receptor regulation. Biochem. Pharmacol. 35 (1986) 1623-1627